Griffiths, C.; Papp, K.; Song, M.; Miller, M.; You, Y.; Shen, Y.-K.; Han, C.; Blauvelt, A. Maintenance of Response With up to 4 Years of Continuous Guselkumab Treatment: Results From the VOYAGE 1 Phase 3 Trial. J of Skin 2019, 3, S17.